Topical pharmaceutical composition comprising at least amitriptyline, for the treatment of peripheral neuropathic pain
AssigneeAlgotherapeutix
InventorCéline Gréco
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a pharmaceutical composition comprising from 10% to 30% by weight of amitriptyline or of a pharmaceutically acceptable salt or ester thereof, relative to the total weight of the composition, amitriptyline, for use in the topical treatment of chemotherapy-induced peripheral neuropathic pain.
Claims5
A pharmaceutical composition for the topical treatment of chemotherapy-induced peripheral neuropathic pain comprising, in a pharmaceutically acceptable carrier suitable for topical application, from 10.5% to 30% by weight, relative to the total weight of the composition, of amitriptyline or a pharmaceutically acceptable salt thereof, from 2% to 8% by weight of one or more surfactants chosen from sorbitan esters, glycerol esters, and mixtures of these compounds, —from 15% to 25% by weight of one or more fatty substances chosen from mineral oils, fatty acids, waxes and mixtures of these compounds, —from 0.1% to 4% by weight of one or more gelling agents chosen from carboxyvinyl polymers, —from 7% to 15% by weight of one or more hydrating active agents, —optionally from 0 to 3% by weight of one or more preservatives, —optionally from 0 to 1% by weight of one or more pH adjusters, and —water;
- wherein the amitriptyline or the pharmaceutically salt thereof is the sole agent for treating neuropathic pain.
A pharmaceutical composition for the topical treatment of chemotherapy-induced peripheral neuropathic pain comprising, in a pharmaceutically acceptable carrier suitable for topical application,
- from 10.5% to 30% by weight of amitriptyline or of a pharmaceutically acceptable salt thereof,
- from 2% to 8% by weight of a mixture of one or more sorbitan esters and of one or more glycerol esters,
- from 15% to 25% by weight of a mixture of one or more mineral oils, of one or more fatty acids and of one or more waxes,
- from 0.1% to 4% by weight of one or more carboxyvinyl polymers,
- from 7% to 15% by weight of glycerol,
- optionally from 0 to 3% by weight of one or more preservatives,
- optionally from 0 to 1% by weight of one or more pH adjusters, and
- water;
- wherein the amitriptyline or the pharmaceutically salt thereof is the sole agent for treating neuropathic pain.
Dependencies are inferred from the claim text.